Susanne Bonsmann

This inventor holds 5 USPTO granted patents and 12 published patent applications and 3 EPO patents. Top assignee: Aicuris Gmbh + Co. Kg.. Active years: 2022-2024.

USPTO Granted Patents = 5 (Patent Applications = 12)

% Patents Active = 100.0

EPO Patents = 3 (Patent Applications = 16)

Average Co-Inventor Count = 5.2

ph-index = 1

Forward Citations = 1(Granted Patents)

Company Filing History:

5 out of 53

Aicuris Gmbh + Co. Kg.

patents

Years Active: 2022-2024

Loading Chart...

5 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12070451 - Sulfate salt of the free base of n-[5-(aminosulfonyl)-4-methyl-1,3-thiazol-2-yl]-n-methyl-2-[4-(2-pyridinyl)-phenyl]-acetamide, pharmaceutical formulations, methods of manufacture and uses thereof (2024-08-27),

2. 11267825 - Highly active amino-thiazole substituted indole-2-carboxamides active against the hepatitis B virus (HBV) (2022-03-08),

3. 11266636 - Maleate salt of the free base of N-[5-(aminosulfonyl)-4-methyl-1,3-thiazol-2-yl]-N-methyl-2-[4-(2-pyridinyl)-phenyl]-acetamide, pharmaceutical formulations, methods of manufacture and uses thereof for the treatment of herpes viruses (2022-03-08),

4. 11236087 - Highly active pyrazolo-piperidine substituted indole-2-carboxamides active against the hepatitis B virus (HBV) (2022-02-01),

5. 11213516 - Intravaginally applicable devices comprising antiviral compounds (2022-01-04),

Title: Susanne Bonsmann: Innovator in Anti-Viral Pharmaceutical Formulations

Introduction

Susanne Bonsmann is a prominent inventor based in Cologne, Germany. She has made significant contributions to the field of anti-viral active agents, particularly through her innovative pharmaceutical formulations. With a total of five patents to her name, her work focuses on the treatment and prevention of human herpes simplex virus infections.

Latest Patents

Bonsmann's latest patents include the sulfate salt of the free base of n-[5-(aminosulfonyl)-4-methyl-1,3-thiazol-2-yl]-n-methyl-2-[4-(2-pyridinyl)-phenyl]-acetamide. This invention relates to the development of pharmaceutical formulations and methods of manufacture for these salts. The formulations are designed for the treatment and prevention of infections caused by HSV-1 and HSV-2, showcasing her commitment to advancing medical science.

Career Highlights

Susanne Bonsmann is currently associated with Aicuris GmbH & Co. KG, where she continues to innovate in the pharmaceutical sector. Her expertise in anti-viral agents has positioned her as a key player in the development of effective treatments for viral infections.

Collaborations

Throughout her career, Bonsmann has collaborated with notable colleagues, including Yogeshwar Bachhav and Alexander Birkmann. These partnerships have further enhanced her research and development efforts in the pharmaceutical field.

Conclusion

Susanne Bonsmann's contributions to anti-viral pharmaceutical formulations highlight her role as a leading inventor in her field. Her innovative patents and collaborations reflect her dedication to improving healthcare outcomes.